Medtronic unveils latest Evolut FX TAVR system for aortic stenosis
Evolut FX upgrades the current Evolut platform with additional capabilities to improve the simplicity of use and predictable…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
19 Sep 22
Evolut FX upgrades the current Evolut platform with additional capabilities to improve the simplicity of use and predictable…
19 Sep 22
The data showed the benefits of Abbott's TriClip for tricuspid regurgitation, MitraClip for treating mitral regurgitation, Amulet for…
19 Sep 22
FDA authorised RECOVER IV randomised controlled trial with the Exception of Informed Consent (EFIC) and approved and closed…
19 Sep 22
SENTINEL is designed for capturing and eliminating embolic debris caused by transcatheter aortic valve replacement (TAVR) before it…
19 Sep 22
New Heart Valve Durability tester with Automatic Dual Control technology debuts at the 34th Transcatheter Cardiovascular Therapeutics (TCT),…
19 Sep 22
Three leading U.S. interventional cardiologists attend initial cases as company prepares to expand its clinical program
16 Sep 22
The PASCAL system comes with independent grasping, atraumatic clasp and closure features and is developed with an intuitive…
15 Sep 22
The second-generation Tri-Ring device uses a two-stage clinical approach and is the first annuloplasty device to specifically meet…
13 Sep 22
Catheter Precision shareholders would own around 80%, and Ra Medical equity holders around 20% of the combined company,…
09 Sep 22
The MitraClip device is a heart valve repair device intended for the treatment of mitral regurgitation